Isotechnika Pharma Inc IPHAF

RE: RE: another day for Roche

[labumba]

    "  If ISA was such a screaming buy, I would think that management would offer to buy Roche's share position in ISA, but they haven't done so. Neither has management been buying in the market "

 Why would ISA , the comapny ,bother to buy Roche's position or any shares in the open market eventhough  the shares at present are way undervalued if they know a major pharma will take over anyway or a partnership/ licencing offer is imminent.

No insiderer trading has been report due to a deal is in a process and possessing some inside info that might directly and indirectly  fluctuate the sp.

I personally believe what is behind the UBS's trading activity is a setup for a major pharma